Summit Therapeutics Inc
NASDAQ:SMMT

Watchlist Manager
Summit Therapeutics Inc Logo
Summit Therapeutics Inc
NASDAQ:SMMT
Watchlist
Price: 17.57 USD -2.33% Market Closed
Market Cap: 13.1B USD

Wall Street
Price Targets

SMMT Price Targets Summary
Summit Therapeutics Inc

Wall Street analysts forecast SMMT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SMMT is 32.93 USD with a low forecast of 12.12 USD and a high forecast of 44.1 USD.

Lowest
Price Target
12.12 USD
31% Downside
Average
Price Target
32.93 USD
87% Upside
Highest
Price Target
44.1 USD
151% Upside
Summit Therapeutics Inc Competitors:
Price Targets
4BB
4Basebio PLC
152% Upside
096530
Seegene Inc
71% Upside
MIRM
Mirum Pharmaceuticals Inc
38% Upside
RNA
Avidity Biosciences Inc
3% Upside
603392
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
8% Upside
IPH
Innate Pharma SA
206% Upside
LCTX
Lineage Cell Therapeutics Inc
144% Upside
KURN
Kuros Biosciences AG
23% Upside

Revenue
Forecast

Revenue Estimate
Summit Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Summit Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Summit Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is SMMT's stock price target?
Price Target
32.93 USD

According to Wall Street analysts, the average 1-year price target for SMMT is 32.93 USD with a low forecast of 12.12 USD and a high forecast of 44.1 USD.

Back to Top